FA pathway
FA cells
FA cases
FANCA mutants
FANCA missense mutations
genetic cause of FA
different FA genes
Fanconi anemia-BRCA pathway
FANCA subcellular localization
nuclear localization of FANCA missense mutants
subcellular mislocalization of FANCA missense mutants
cure
common DNA repair pathway
Fanconi anemia Fanconi anemia
patient-derived missense mutations
DNA coss
heterogeneous genetic diseases
study
functionality
sites of DNA damage
cancer predisposition
unbiased approaches
cancer treatment difficult
large subset of patients
unbiased high-throughput approach
bone marrow failure
BRCA2
agents
D1
molecular mechanisms
screen
chemotherapy
malformations
key step
effective way
impact
BRCA1
combination of targeted
valuable information
drugs
correction
life expectancy
system
cytoplasm
pathogenicity
Personalized medicine-based therapies
FANCD2 ubiquitination
option
years
potential
addition
Reactivation
nucleus
summary
mechanism of action
accounting
project
application